Harvard Bioscience, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBIO research report →
About the company
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.
- CEO
- John D. Duke
- IPO
- 2001
- Employees
- 331
- HQ
- Holliston, MA, US
Price Chart
- Market Cap
- $27.74M
- P/E
- -2.79
- P/S
- 0.32
- P/B
- 2.74
- EV/EBITDA
- -34.63
- Div Yield
- 0.00%
- Gross Margin
- 57.06%
- Op Margin
- 1.39%
- Net Margin
- -11.44%
- ROE
- -73.04%
- ROIC
- 2.11%
- Revenue
- $86.55M · -8.06%
- Net Income
- $-56,700,000 · -357.07%
- EPS
- $-12.80 · -357.14%
- Op Income
- $-629,000
- FCF YoY
- 408.01%
- 52W High
- $9.40
- 52W Low
- $3.80
- 50D MA
- $6.13
- 200D MA
- $5.77
- Beta
- 1.50
- Avg Volume
- 39.91K
Get TickerSpark's AI analysis on HBIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | Eade Katherine A. | other | 16,556 |
| Jun 9, 26 | Snider William | other | 16,556 |
| Jun 9, 26 | DENELSKY STEPHEN J | other | 16,556 |
| Jun 9, 26 | Gagnon Robert E. | other | 16,556 |
| Jun 9, 26 | Benson Seth Benjamin | other | 16,556 |
| Mar 20, 26 | Frost Mark T | other | 30,000 |
| Mar 16, 26 | Frost Mark T | buy | 5,000 |
| Mar 20, 26 | Duke John D | other | 75,000 |
| Mar 17, 26 | DENELSKY STEPHEN J | buy | 10,000 |
| Mar 17, 26 | Snider William | buy | 8,475 |
Our HBIO coverage
Recent articles, reports, and earnings notes.
No research on HBIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HBIO report →Similar companies
Peers in the same neighborhood.